Giacomo Oliveira

Jun 25, 2024 | nature.com | Remy Petremand |Johanna Chiffelle |Marion Arnaud |David Barras |Maria Lozano-Rabella |Raphael Genolet | +6 more

Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-024-02232-0, published online 7 May 2024In the version of the article initially published, there were errors in Extended Data Fig. 5e. One patient was erroneously omitted due to an inaccurate y-axis scale, and in the key “n = 17” has been corrected to “n = 12”. These corrections have been made to the HTML and PDF versions of the article.

Jun 25, 2024 | nature.com | Remy Petremand |Johanna Chiffelle |Marion Arnaud |David Barras |Maria Lozano-Rabella |Raphael Genolet | +6 more

Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-024-02232-0, published online 7 May 2024In the version of the article initially published, there were errors in Extended Data Fig. 5e. One patient was erroneously omitted due to an inaccurate y-axis scale, and in the key “n = 17” has been corrected to “n = 12”. These corrections have been made to the HTML and PDF versions of the article.

May 7, 2024 | nature.com | Remy Petremand |Johanna Chiffelle |Marion Arnaud |David Barras |Maria Lozano-Rabella |Raphael Genolet | +6 more

AbstractA central challenge in developing personalized cancer cell immunotherapy is the identification of tumor-reactive T cell receptors (TCRs).

May 7, 2024 | nature.com | Remy Petremand |Johanna Chiffelle |Marion Arnaud |David Barras |Maria Lozano-Rabella |Raphael Genolet | +6 more

AbstractA central challenge in developing personalized cancer cell immunotherapy is the identification of tumor-reactive T cell receptors (TCRs).

Sep 8, 2023 | science.org | Giacomo Oliveira |Jonna Alanko |Paul Brennan

Published In Science ImmunologyVolume 8 | Issue 87September 2023Article versionsSubmission historyReceived: 15 February 2023Accepted: 8 August 2023PermissionsRequest permissions for this article. AcknowledgmentsWe thank E. Dissen (University of Oslo, Norway) for providing KIR2DS1 reporter cells. Funding: This work was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases. Author contributions: M.J.W.S. and E.O.L. conceived the study.